Medication Persistence and Health Care Expenditures in a Managed Medicaid Population With Asthma
April 17th 2009A retrospective review of administrative claims data was conducted to identify health plan members with asthma who were persistent with their controller medications and those who were not persistent. Utilization of health care services and associated costs were measured for both groups. Non-persistent use of controller medications resulted in more asthma-related emergency department visits and home health services whereas persistent controller use was associated with more physician office and outpatient visits. Mean asthma-related medical costs per member were greater in the non-persistent cohort ($577.62) than in the persistent cohort ($323.03). These findings support the need for targeted interventions to address non-persistence in a managed Medicaid population.(Drug Benefit Trends. 2009;21:112-118)
MA Plans Face Harsher Rules for 2010
April 16th 2009Medicare Advantage (MA) plans will feel a major effect next year from the switchover from the Bush administration to the Obama administration. One of the first actions taken by President Barack Obama-just 2 days after his inauguration-was to revoke the 2010 draft Call Letter that the Centers for Medicare & Medicaid Services (CMS) had issued for MA plans. The new draft Call Letter suggests harsher rules and more oversight in a number of specific areas.
Persons With Chronic Conditions Ill-Served by Health Care System
April 16th 2009Many persons with chronic conditions are not getting the care and support they seek from the health care system, according to findings of a survey of 1109 persons aged 44 years and older with at least 1 chronic condition, stratified as baby boomers (aged 44 to 63) and seniors (aged 65 and older). Among their biggest complaints, persons with chronic health conditions say their physicians do not spend enough time with them. They also report having had to put off care because of cost.
Complex Issues Surround EHR Adop
April 16th 2009Recently, I accompanied my mother to the hospital for cataract surgery and, the next day, to the eye surgeon’s for a follow-up visit. Both the hospital and the doctor’s office still use paper records exclusively. Multicolored folders filled floor-to-ceiling file cabinets that took up most of the doctor’s outer office while the hospital keeps its mostly handwritten patient records in 3-ring binders. The surgery took just 15 minutes and resulted in crystal-clear 20/20 vision in the affected eye. Impressive, especially considering that my mother is 81 years old.
Update on Therapy for Histoplasmosis
April 13th 2009Histoplasmosis is caused by the dimorphic fungus Histoplasma capsulatum, which is endemic to the Ohio and Mississippi river valleys. It is associated with a variety of manifestations, and its severity ranges from asymptomatic infection to severe disseminated illness.
New Advances in Antiretroviral Therapy
April 13th 2009It is estimated that approximately 33.2 million persons worldwide were living with HIV infection in 2007.1 With the development of effective antiretroviral treatment strategies, HIV infection has now become a manageable chronic disease.2 Despite advances in treatment, drug resistance, long-term adverse effects, and high adherence requirements represent ongoing challenges to durable viral suppression.
HSV-1 Encephalitis Complicated by Cerebral Hemorrhage in an HIV-Positive Person
April 2nd 2009Herpes simplex virus type 1 (HSV-1) is the most common cause of sporadic encephalitis worldwide. In the California Encephalitis Project, 24% of the cases of viral encephalitis were caused by HSV-1 and 3% were caused by HSV-2.1
HIV-Related Lipodystrophy in Africa and Asia
April 1st 2009In 2005, members of the Group of Eight (G8)-an international forum for the governments of Canada, France, Germany, Italy, Japan, Russia, the United Kingdom, the United States, and the European Union-along with the African Union and the heads of state attending the 2005 United Nations World Summit, joined with the UNAIDS Secretariat in committing themselves to providing universal access to HIV care, prevention, and treatment for all those in need by 2010.
A Breathtaking Experience for Kids
April 1st 2009Although children can usually inhale very well during lung auscultation, typically they do not exhale sufficiently. I ask them to “breathe in real big and then let all the air out without being noisy.” I place one hand on their chest and the other on their back; I let them inhale, and when they start to exhale, I gently compress the chest to accentuate the breath sounds and to obtain a full exhalation. Children tolerate this very well.
Strengthen the Response to Iron Therapy
April 1st 2009When a patient with iron deficiency anemia fails to respond to oral iron supplementation, consider whether foods he or she is consuming may be contributing to malabsorption. Such foods include coffee and tea (because they contain tannins) and cola drinks (a result of their phosphate content). In addition, because achlorhydria may interfere with iron absorption, encourage patients to eat foods rich in vitamin
CROI 2009: A Few Key Presentations on Antiretroviral Therapy
April 1st 2009In contrast to previous conferences, at this year’s Conference on Retroviruses and Opportunistic Infections (CROI), held February 8 through 11 in Montreal, there were few presentations on major clinical trials of antiretroviral therapy and little news on investigational agents was reported. Nevertheless, there were a number of important studies dealing with the treatment of HIV infection, a few of which I’ll summarize here.
When to Resist the Temptation to Transfuse
April 1st 2009Here is a common clinical scenario. Your patient was admitted to the hospital with an acute myocardial infarction (MI). Intervention has been successful, and the patient's condition is now stable. The cardiologist is concerned about the patient's hemoglobin value of 9 g/dL. Active bleeding, hemolysis, and other potential causes of anemia (iron or vitamin B12 deficiency, for example) have been excluded. The decision is made to transfuse to raise the hemoglobin level above 10 g/dL.